Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.
Hatano
Kazuo
K
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co, Ltd, Osaka, Japan. kazuo_hatano@po.fujisawa.co.jp
Morishita
Yoshihiko
Y
Nakai
Toru
T
Ikeda
Fumiaki
F
D001232:Aspergillus fumigatus / Q000187:drug effects*; D002176:Candida albicans / Q000187:drug effects*; D054714:Echinocandins; D005964:Glucosyltransferases / Q000187:drug effects; D007700:Kinetics; D055666:Lipopeptides; D008074:Lipoproteins / Q000494:pharmacology*; D008565:Membrane Proteins; D000077551:Micafungin; D010456:Peptides, Cyclic / Q000494:pharmacology*; D029702:Schizosaccharomyces pombe Proteins
D054714:Echinocandins; D055666:Lipopeptides; D008074:Lipoproteins; D008565:Membrane Proteins; D010456:Peptides, Cyclic; D029702:Schizosaccharomyces pombe Proteins; D005964:Glucosyltransferases; C020570:1,3-beta-glucan synthase; D000077551:Micafungin